This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
| Yesterday’s UK 100 Leaders | Price (p) | % Chg |
| Entain PLC | 669.6 | 6.3% |
| Smiths Group PLC | 1,862.0 | 5.5% |
| Spirax Group PLC | 7,270.0 | 5.0% |
| Prudential PLC | 655.6 | 4.9% |
| Anglo American PLC | 2,548.0 | 3.6% |
| Yesterday’s UK 100 Laggards | Price (p) | % Chg |
| JD Sports Fashion PLC | 85.0 | -2.7% |
| Fresnillo PLC | 666.0 | -2.1% |
| Marks And Spencer Group PLC | 334.5 | -0.5% |
| Auto Trader Group PLC | 793.6 | -0.3% |
| London Stock Exchange Group PLC | 11770.0 | -0.2% |
| Major World Indices | Price | % Chg | 1 Year |
| UK 100 INDEX | 8,505 | 1.4% | 14.0% |
| DOW JONES INDUS. AVG | 43,488 | 0.8% | 14.9% |
| DAX INDEX | 20,903 | 1.2% | 26.3% |
| NIKKEI 225 | 38,903 | 1.2% | 8.2% |
| S&P/ASX 200 INDEX | 8,347 | 0.5% | 12.5% |
| Commodities | Units | Price | % Chg |
| WTI Crude Oil (Nymex) | USD/bbl. | 77.88 | 0.00% |
| Brent Crude (ICE) | USD/bbl. | 80.62 | -0.21% |
| Gold Spot | USD/t oz. | 2,707 | 0.1% |
| Copper (Comex) | USd/lb. | 435 | -0.5% |
Click graph to enlarge
The UK 100 called to open -16 points at 8,489. The UK 100 looks set to open marginally lower this morning, having closed out last week at all time highs, having broken through the 8500 mark for the first time.
It was a positive day Stateside on Friday also, the Dow Jones added 334.70 points, or 0.78%, to end at 43,487.83. The S&P gained 1% to 5,996.66, and the Nasdaq advanced 1.51% to 19,630.20. Big tech stocks were higher on the day, with shares of Tesla popping 3%. Chipmaking giant Nvidia jumped 3.1%, while Alphabet shares added more than 1%.
Donald Trump’s inauguration will be in focus as the president-elect returns to the White House for a second term today. Eyes will be on any rapid executive orders, after Trump has signalled plans for the likes of sweeping tariffs and energy sector deregulation.
AstraZeneca’s Datroway (datopotamab deruxtecan) approved in the US for patients with previously treated metastatic HR-positive, HER2-negative breast cancer. First approval in the US for AstraZeneca and Daiichi Sankyo’s Datroway based on TROPION-Breast01 results showing 37% reduction in the risk of disease progression or death vs. chemotherapy. Datroway is the eighth new medicine of the 20 AstraZeneca has set out to deliver by 2030.
GSK this morning said that the European Commission had expanded Jemperli (dostarlimab) plus chemotherapy approval to all adult patients with primary advanced or recurrent endometrial cancer.
John Wood Group PLC has been awarded a significant new contract to provide long-term maintenance solutions foronshore and offshore assets in the Gippsland Basin, Victoria, operated by Esso Australia.
No New Broker Comments
UK
None
US
None
UK
4imprint Group
Kier Group
Premier Foods
US
3M Co
Netflix
President Trump Inaugeration
Martin Luther King Day (US Public Holiday)
PBoC Interest Rate Decision
German Producer Price Index
UK 100 companies going ex-dividend on 23rd January 2025:
Games Workshop Group
UK 250 companies going ex-dividend on 23rd January 2025:
Foresight Solar Fund
Victrex
City of London Investment Trust
NB Private Equity Partners
Bankers Investment Trust
For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.